TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity
63Citations signalées
10Institutions associées
1Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.
Institutions
Cincinnati Children's Hospital Medical CenterNYU Langone’s Laura and Isaac Perlmutter Cancer CenterNew York UniversityUniversity of South CarolinaUniversity of Cincinnati Medical CenterNew York Genome CenterIcahn School of Medicine at Mount SinaiMemorial Sloan Kettering Cancer CenterHoward Hughes Medical InstituteKettering University
Sujets associés
Acute Myeloid Leukemia ResearchUbiquitin and proteasome pathwaysHistone Deacetylase Inhibitors Research